Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Wilma, Hopman"'
Publikováno v:
Current Oncology, Vol 31, Iss 7, Pp 3939-3948 (2024)
(1) Purpose: The purpose of this study was to describe the outcomes of diagnostic breast imaging and the incidence of delayed breast cancer diagnosis in the study population. (2) Methods: We collected the outcome data from diagnostic mammograms and/o
Externí odkaz:
https://doaj.org/article/fffb3fe6962a416a8bdd1e0a78bbdd46
Publikováno v:
Journal of the Canadian Health Libraries Association, Vol 45, Iss 3 (2024)
Introduction: The objectives of this comparative study were 1) to compare the effectiveness of in-person classroom instruction versus an online video for teaching literature searching skills to graduate students, and 2) to evaluate their perceptions
Externí odkaz:
https://doaj.org/article/05b7ce704b274145be266c8ffc7885b8
Publikováno v:
Medical Education Online, Vol 29, Iss 1 (2024)
Introduction Since 2022, all Canadian post-graduate medical programs have transitioned to a Competence by Design (CBD) model within a Competency-Based Medical Education (CBME) framework. The CBME model emphasized more frequent, formative assessment o
Externí odkaz:
https://doaj.org/article/ca225aeaaf064f2aa4ddfedbf7b0aef2
Autor:
Sawmmiya Kirupaharan, Roumen Milev, Joanne Bressee, Sonya Kelso, Scott Duggan, Felicia Iftene, Tim V. Salomons, Wilma Hopman, Ian Gilron
Publikováno v:
Canadian Journal of Pain, Vol 8, Iss 1 (2024)
ABSTRACTIntroduction Pain management in patients with chronic pain and comorbid depression is challenging and understudied. There is interest in intermittent theta-burst stimulation (iTBS), a new modality of repetitive transcranial magnetic stimulati
Externí odkaz:
https://doaj.org/article/d4e92dd040324676a25614906f9d6bd8
Autor:
Navdeep Dehar, M.B.B.S., MD, MBT, FRCPC, Mahbuba Meem, MD, Ishita Aggarwal, MD, MPH, Wilma Hopman, MA, Pierre-Olivier Gaudreau, MD, PhD, MPs, FRCPC, Andrew Robinson, MD, MSc, FRCPC, Andrea S. Fung, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100696- (2024)
Introduction: The CASPIAN and IMpower133 trials revealed a significant survival benefit of chemotherapy plus immunotherapy in patients with extensive-stage SCLC. The current study characterizes the proportion of real-world patients who would have met
Externí odkaz:
https://doaj.org/article/2b015a074b004deab02cf52cc5fd4acc
Autor:
Nikita Arora, Marcus Lo, Nader M. Hanna, Jennifer Pereira, Geneviève Digby, Robert Bechara, Shaila J. Merchant, Wilma Hopman, Shirley Li, Andrew Giles, Wiley Chung
Publikováno v:
Cancer Medicine, Vol 12, Iss 10, Pp 11907-11914 (2023)
Abstract Background Patient navigation (P.N.) is designed to eliminate barriers to care. The objective of this study was to evaluate the impact of a novel P.N. program on timeliness of care in patients with esophageal cancer. Methods This retrospecti
Externí odkaz:
https://doaj.org/article/5cdbfbbc22e241f787dc0e1ba8ddfc73
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7953-7963 (2022)
ICI therapy has greatly improved patient outcomes in melanoma, but at the cost of immune-related adverse events (irAEs). Data on the chronicity of irAEs, especially in real-world settings, are currently limited. We performed a retrospective chart rev
Externí odkaz:
https://doaj.org/article/e332e4c30463432db8962851eacdcde0
Autor:
Cameron Giles, Milica Novakovic, Wilma Hopman, Erin F. Barreto, William Beaubien-Souligny, Peter Birks, Javier A. Neyra, Ron Wald, Samuel A. Silver
Publikováno v:
Canadian Journal of Kidney Health and Disease, Vol 10 (2023)
Background: Acute kidney injury (AKI) increases the risk of hospital readmission, chronic kidney disease, and death. Therefore, effective communication in discharge summaries is essential for safe transitions of care. Objective: The objectives of thi
Externí odkaz:
https://doaj.org/article/0a9c1cd3b067416799098ca89e37feb7
Autor:
Stephane Thibodeau, Mahbuba Meem, Wilma Hopman, Simran Sandhu, Osbert Zalay, Andrea S. Fung, Adi Kartolo, Geneviève C. Digby, Shahad Al-Ghamdi, Andrew Robinson, Allison Ashworth, Timothy Owen, Aamer Mahmud, Kit Tam, Timothy Olding, Fabio Ynoe de Moraes
Publikováno v:
Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100747- (2023)
Purpose/Objective: Around 30% of patients with non-small cell lung cancers (NSCLC) are diagnosed with stage III disease at presentation, of which about 50% are treated with definitive chemoradiation (CRT). Around 65–80% of patients will eventually
Externí odkaz:
https://doaj.org/article/3d8d681f93cc4264a88179a2b79a4362
Publikováno v:
Cancer Treatment and Research Communications, Vol 34, Iss , Pp 100678- (2023)
Background: Durvalumab following chemoradiation in unresectable stage III non-small cell lung cancer (NSCLC) has led to improved outcomes. The schedule of administration has been determined by pharmacokinetic studies. This study evaluates real-world
Externí odkaz:
https://doaj.org/article/db24fa5f885a41e9a97d5fd877c12930